Studies have shown that CD8+ T cells in patients with COVID-19 are usually observed within 7 days of symptom onset, with level peaking at 14 days (Figure 3) (210, 214), and are more activated than CD4+ T cells (142, 215, 216). The gene discussed is CD8A; the disease is COVID-19.